close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by CareDx, Inc.

< Previous 1 2 3 4 Next >
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Third Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Third Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces CEO Transition
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx To Present at the 2023 Cantor Global Healthcare Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports Second Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report Second Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx’s HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics Company
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx’s AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Reports First Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx to Report First Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation
From CareDx, Inc.
Via Business Wire
Tickers CDNA
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
From CareDx, Inc.
Via Business Wire
Tickers CDNA MIRO
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association
From CareDx, Inc.
Via Business Wire
Tickers CDNA
The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance
From CareDx, Inc.
Via Business Wire
Tickers CDNA
CareDx Update Regarding Raymond James & Associates’ Conference
From CareDx, Inc.
Via Business Wire
Tickers CDNA
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today